Quarterly Transactions Made in Prelude Therapeutics Inc (PRLD)
This table provides information about the institutional ownership of Prelude Therapeutics Inc (PRLD). The information is specifically focused on institutions that hold shares of Prelude Therapeutics Inc.
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 1,018,260 | 1,067,575 | 2,085,835 | 294,314 | 71,690 | 366,004 | 1,719,831 | |
Q4 2021 | 1,281,244 | 1,336,826 | 2,618,070 | 2,315,448 | 885,522 | 3,200,970 | -582,900 | |
Q1 2022 | 1,426,162 | 111,999 | 1,538,161 | 1,881,044 | 662,469 | 2,543,513 | -1,005,352 | |
Q2 2022 | 680,706 | 323,862 | 1,004,568 | 2,258,592 | 180,308 | 2,438,900 | -1,434,332 | |
Q3 2022 | 465,509 | 149,353 | 614,862 | 950,970 | 0 | 950,970 | -336,108 | |
Q4 2022 | 297,255 | 172,837 | 470,092 | 469,157 | 0 | 469,157 | 935 | |
Q1 2023 | 380,463 | 839,692 | 1,220,155 | 419,744 | 0 | 419,744 | 800,411 | |
Q2 2023 | 5,939,684 | 1,571,400 | 7,511,084 | 173,328 | 0 | 173,328 | 7,337,756 | |
Q3 2023 | 890,245 | 417,586 | 1,307,831 | 996,840 | 0 | 996,840 | 310,991 | |
Q4 2023 | 643,551 | 4,222,160 | 4,865,711 | 5,239,845 | 0 | 5,239,845 | -374,134 | |
Q1 2024 | 120,188 | 112,441 | 232,629 | 542,370 | 0 | 542,370 | -309,741 | |
Q2 2024 | 59,917 | 66,143 | 126,060 | 226,100 | 0 | 226,100 | -100,040 | |
Q3 2024 | 794,220 | 2,796,046 | 3,590,266 | 1,325,269 | 0 | 1,325,269 | 2,264,997 |